FDA Approval Of Hepatitis C Drugs For Kids Is Likely To Speed Treatment

CU study examines the role of lactate in cancer and why exercise reduces cancer risks
May 1, 2017
Study shows that cycling to work could cut risk of cancer by 45 percent
May 1, 2017
Show all

FDA Approval Of Hepatitis C Drugs For Kids Is Likely To Speed Treatment

FDA has approved hepatitis C treatments for kids.

With the approval this month of two drugs to treat hepatitis C in children, these often overlooked victims of the opioid epidemic now have a better chance at a cure. Kids may actually have an easier time than adults getting approved for the treatment, according to some health policy specialists.

Researchers estimate that 23,000 to 46,000 children in the United States are infected with hepatitis C, a blood-borne infection that causes inflammation of the liver and can lead to liver failure, cancer and death. Most of the estimated 2.7 million to 3.9 million people overall who have chronic hepatitis C in the U.S. got it from sharing needles and other equipment while injecting opioids or other illicit drugs or (especially in earlier decades) from transfusions of contaminated blood.

But only about 20 percent of children get it from drug use. The majority of kids become infected by their mom during pregnancy. A baby has about a 6 percent chance of contracting hepatitis C if their mother has it.

Read full article: FDA Approval Of Hepatitis C Drugs For Kids Is Likely To Speed Treatment

Read Full Article: FDA Approval Of Hepatitis C Drugs For Kids Is Likely To Speed Treatment

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.